September 28, 2022 – September 28, 2022 – FACIT congratulates Ontario-based start-ups Hyivy Health and HDAX Therapeutics as the latest recipients of capital through its Prospects Oncology Fund. Selected among a top-tier pool of applicants, these Ontario-based innovations illustrate excellent potential to benefit patients with cancer.
Category: Uncategorized
FACIT’s David O’Neill shares strategy for Ontario intellectual property
June 16, 2022 – The paper “How to boost Ontario’s life sciences IP to help patients and the economy” discusses the importance of seed-stage investing and commercialization-venture partnerships to reap the benefits of taxpayers’ investment in post-secondary education and health research.
Read More from FACIT’s David O’Neill shares strategy for Ontario intellectual property
FACIT invests in OICR’s groundbreaking approaches to integrated drug discovery and cancer informatics
April 28, 2022 – April 27, 2022 – FACIT announced two recent strategic investments from its Prospects Oncology Fund in innovations arising from renowned cancer experts at the Ontario Institute for Cancer Research (OICR): Dr. Rima Al-awar, Head of Therapeutic Innovation and Drug Discovery, and Dr. Lincoln Stein, Head of Adaptive Oncology.
FACIT announces winner of 2022 Falcons’ Fortunes pitch competition on World Cancer Day
February 4, 2022 – February 4, 2022 – FACIT is pleased to announce the 2022 winner of its Falcons’ Fortunes pitch competition: Point Surgical Inc.. Point Surgical was founded as a joint venture between Toronto’s University Health Network, Unity Health Toronto and Light Matter Interaction Inc.
High-potency TIL cell therapy approach reported using CytoFind platform developed by FACIT portfolio company Cellular Analytics
January 27, 2022 – January 27, 2022 – FACIT congratulates portfolio company Cellular Analytics on a recent publication by its CSO, Dr. Shana Kelley and collaborators, on the Company’s tumor-infiltrating lymphocyte (TIL) therapeutics platform.
Registration is now open for FACIT Falcons’ Fortunes virtual pitch competition
January 11, 2022 – Now in its 9th year, the FACIT Falcons’ Fortunes event is back for 2022! Be part of the audience and watch the six finalists pitch their Ontario oncology innovations.
Read More from Registration is now open for FACIT Falcons’ Fortunes virtual pitch competition
FACIT portfolio company and leader in synthetic health data, Replica Analytics, acquired by New York-based Aetion
January 11, 2022 – January 7, 2022 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it.
FACIT broadens Executive-in-Residence program to capitalize on Ontario IP
November 30, 2021 – November 4, 2021 – The appointment broadens the available expertise to provide critical senior management and leadership to create and nurture FACIT start-ups in Ontario.
Read More from FACIT broadens Executive-in-Residence program to capitalize on Ontario IP
FACIT Features: Radiant Biotherapeutics, next-gen biotech developing multabody therapies for cancer
October 21, 2021 – October 21, 2021 – Radiant received a seed investment from FACIT’s Compass Rose Oncology Fund.
FACIT Features: Replica Analytics, Ottawa-based start-up in health data artificial intelligence
October 13, 2021 – October 13, 2021 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it.